Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety.

Haber P, Iskander J, Walton K, Campbell SR, Kohl KS.

Pediatrics. 2011 May;127 Suppl 1:S39-44. doi: 10.1542/peds.2010-1722G. Epub 2011 Apr 18.

PMID:
21502243
2.

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.

Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT.

Pediatr Infect Dis J. 2004 Apr;23(4):287-94. Review.

PMID:
15071280
3.

Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.

Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; VAERS team.

Vaccine. 2008 Feb 26;26(9):1166-72. doi: 10.1016/j.vaccine.2007.12.049. Epub 2008 Jan 22. Review.

PMID:
18255204
4.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
5.

Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ; Anthrax Vaccine Export Committee.

Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):189-202. Review.

PMID:
12051118
6.

Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, Ward BJ, West DJ.

Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. Review.

PMID:
15386719
7.

Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.

Chang S, Ball R, Braun MM.

Vaccine. 2008 May 2;26(19):2428-32. doi: 10.1016/j.vaccine.2008.02.052. Epub 2008 Mar 17. Review.

PMID:
18406499
8.

Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.

Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N; H1N1 Working Group of Federal Immunization Safety Task Force.

Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Epub 2011 Apr 18. Review.

PMID:
21502251
9.

A review of the Vaccine Adverse Event Reporting System database.

Geier DA, Geier MR.

Expert Opin Pharmacother. 2004 Mar;5(3):691-8. Review.

PMID:
15013937
10.

Vaccine safety.

Jacobson RM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):589-603. Review.

PMID:
14753382
11.

Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.

Kanesa-thasan N, Shaw A, Stoddard JJ, Vernon TM.

Pediatrics. 2011 May;127 Suppl 1:S16-22. doi: 10.1542/peds.2010-1722D. Epub 2011 Apr 18. Review.

PMID:
21502248
12.

Vaccine and Immunization Surveillance in Ontario (VISION) - using linked health administrative databases to monitor vaccine safety.

Wilson K, Hawken S, Kwong JC, Deeks SL, Crowcroft NS, Manuel D.

Vaccine. 2012 Sep 21;30(43):6115-20. doi: 10.1016/j.vaccine.2012.06.004. Epub 2012 Jun 15. Review.

PMID:
22709951
13.

Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System.

Zheteyeva Y, Moro PL, Yue X, Broder K.

Am J Obstet Gynecol. 2013 Jun;208(6):478.e1-6. doi: 10.1016/j.ajog.2013.02.027. Epub 2013 Feb 20. Review.

PMID:
23453881
14.

Data mining in the US using the Vaccine Adverse Event Reporting System.

Iskander J, Pool V, Zhou W, English-Bullard R; VAERS Team.

Drug Saf. 2006;29(5):375-84. Review.

PMID:
16689554
15.

Biologically plausible and evidence-based risk intervals in immunization safety research.

Rowhani-Rahbar A, Klein NP, Dekker CL, Edwards KM, Marchant CD, Vellozzi C, Fireman B, Sejvar JJ, Halsey NA, Baxter R; Risk Interval Working Group of the Clinical Immunization Safety Assessment Network.

Vaccine. 2012 Dec 17;31(1):271-7. doi: 10.1016/j.vaccine.2012.07.024. Epub 2012 Jul 24. Review.

PMID:
22835735
16.

Adverse events following immunization: real causality and myths.

Principi N, Esposito S.

Expert Opin Drug Saf. 2016 Jun;15(6):825-35. doi: 10.1517/14740338.2016.1167869. Epub 2016 Apr 1. Review.

PMID:
26986067
17.

Enhancing vaccine safety capacity globally: A lifecycle perspective.

Chen RT, Shimabukuro TT, Martin DB, Zuber PL, Weibel DM, Sturkenboom M.

Vaccine. 2015 Nov 27;33 Suppl 4:D46-54. doi: 10.1016/j.vaccine.2015.06.073. Epub 2015 Oct 1. Review.

18.

Why some messages speak better: child immunization in the news and on the internet.

Rundblad G.

Curr Drug Saf. 2015;10(1):87-93. Review.

PMID:
25859681
19.

Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines.

Verstraeten T, DeStefano F, Chen RT, Miller E.

Expert Rev Vaccines. 2003 Feb;2(1):21-9. Review.

PMID:
12901594
20.

Toward interactive, Internet-based decision aid for vaccination decisions: better information alone is not enough.

Connolly T, Reb J.

Vaccine. 2012 May 28;30(25):3813-8. doi: 10.1016/j.vaccine.2011.12.094. Epub 2012 Jan 9. Review.

PMID:
22234264

Supplemental Content

Support Center